In vivo hepatitis B virus-neutralizing activity of an anti-HBsAg humanized antibody in chimpanzees

Experimental and Molecular Medicine

Volumn 40, Issue 1, 2008, Pages 145-149

  Se, Ho Kim ^a   Han, Kyu Oh ^a,c   Chun, Jeih Ryu ^b,d   Song, Yong Park ^a   Hyo, Jeong Hong ^b  

^a Green Cross Company   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Neurotech Pharmaceuticals   (South Korea)

^d Sejong University   (South Korea)

Author keywords

Antibodies, monoclonal; Hepatitis B surface antigens; Hepatitis B virus; Immunization, passive; Immunotherapy; Pan troglodytes

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CHIMPANZEE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEPATITIS B; HEPATITIS B VIRUS; IMMUNOPROPHYLAXIS; IN VIVO STUDY; NONHUMAN; SINGLE DRUG DOSE; VIRUS NEUTRALIZATION; VIRUS STRAIN;

HEPATITIS B VIRUS; PAN; PAN TROGLODYTES;

EID: 40449090328     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2008.40.1.145     Document Type: Article

References (29)